# SR-BI and Antiviral Treatment Response in HCV

> **NCT02714712** · — · COMPLETED · sponsor: **Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation** · enrollment: 309 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Peginterferon alfa-2a

## Key facts

- **NCT ID:** NCT02714712
- **Lead sponsor:** Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-07
- **Final completion:** 2016-08
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2017-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714712, "SR-BI and Antiviral Treatment Response in HCV". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02714712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*